Physician profile
Michael E Jessen
NPI 1275597015
$21,036.21
in general payments reported to CMS, 2019-2025
21 companies · $9,643 in 2025
The $9,643 reported for 2025 was more than what 89% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,289 · 2020: $287 · 2021: $425 · 2022: $1,707 · 2023: $2,743 · 2024: $3,943 · 2025: $9,643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,981 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,400 · Food and Beverage: $4,947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,981.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,400.00 |
| Food and Beverage | $4,946.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $9,884.56 | 2023-2025 | Igt Devices Undivided, (9520) Igt Devices Und, Lm Undivided |
| Edwards Lifesciences Corporation | $3,675.67 | 2019-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve, Konect Resilia |
| Cerus Corporation | $2,620.80 | 2024 | Intercept Blood System For Platelets |
| Alexion Pharmaceuticals, INC. | $1,379.41 | 2025 | Ultomiris |
| Medtronic, INC. | $950.28 | 2022 | |
| Baxter Healthcare | $629.38 | 2019-2025 | Coseal, Preveleak, Perclot |
| Intuitive Surgical, INC. | $458.19 | 2022 | |
| Medtronic Vascular, INC. | $428.86 | 2019-2020 | |
| Bolton Medical INC | $215.31 | 2024 | Treo Abdominal Stent-Graft System |
| Artivion, INC. | $196.50 | 2019 | |
| Atricure, INC. | $192.98 | 2019-2022 | |
| Kls-Martin L.P. | $164.41 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $56.25 | 2024 | Pectus Bar Bending Forceps, Standard |
| Getinge USA Sales, LLC | $52.07 | 2025 | Vasoview Hemopro 2 |
| Lemaitre Vascular, INC. | $35.58 | 2024 | Restoreflow |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $30.72 | 2025 | |
| Lidco Group Plc | $20.82 | 2019 | |
| Abiomed | $20.54 | 2024 | Impella |
| Abbott Laboratories | $20.00 | 2021 | |
| Zoll Circulation INC | $3.88 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Jessen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.